Healx

Cambridge-based Healx applies AI to drug discovery with a distinctive focus on rare diseases - conditions often overlooked because individual patient populations are small.

Its models predict promising treatments and combinations, including repurposing existing drugs, to bring therapies to underserved patients faster. The approach pairs AI predictions with biological validation.

It is a notable example of pointing AI drug discovery at areas the market has historically neglected.